Sporn M - Search Results - PubMed

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: Sporn M - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

519 results

Page of 52

Results are displayed in a computed author sort order. The Publication Date timeline is not available.

Page 1

1

Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAIL.

Suh WS, Kim YS, Schimmer AD, Kitada S, Minden M, Andreeff M, Suh N, Sporn M, Reed JC. Suh WS, et al. Among authors: sporn m. Leukemia. 2003 Nov;17(11):2122-9. doi: 10.1038/sj.leu.2403112. Leukemia. 2003. PMID: 12931220

2

An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis.

Kim Y, Suh N, Sporn M, Reed JC. Kim Y, et al. Among authors: sporn m. J Biol Chem. 2002 Jun 21;277(25):22320-9. doi: 10.1074/jbc.M202458200. Epub 2002 Apr 8. J Biol Chem. 2002. PMID: 11940602 Free article.

3

The triterpenoid CDDO induces apoptosis in refractory CLL B cells.

Pedersen IM, Kitada S, Schimmer A, Kim Y, Zapata JM, Charboneau L, Rassenti L, Andreeff M, Bennett F, Sporn MB, Liotta LD, Kipps TJ, Reed JC. Pedersen IM, et al. Among authors: sporn mb. Blood. 2002 Oct 15;100(8):2965-72. doi: 10.1182/blood-2002-04-1174. Blood. 2002. PMID: 12351409 Free article.

4

Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells.

Hyer ML, Croxton R, Krajewska M, Krajewski S, Kress CL, Lu M, Suh N, Sporn MB, Cryns VL, Zapata JM, Reed JC. Hyer ML, et al. Among authors: sporn mb. Cancer Res. 2005 Jun 1;65(11):4799-808. doi: 10.1158/0008-5472.CAN-04-3319. Cancer Res. 2005. PMID: 15930300 Free article.

5

Evidence supporting a role for calcium in apoptosis induction by the synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO).

Hail N Jr, Konopleva M, Sporn M, Lotan R, Andreeff M. Hail N Jr, et al. Among authors: sporn m. J Biol Chem. 2004 Mar 19;279(12):11179-87. doi: 10.1074/jbc.M312758200. Epub 2004 Jan 7. J Biol Chem. 2004. PMID: 14711815 Free article.

6

Chemoprevention of cancer.

Sporn MB, Suh N. Sporn MB, et al. Carcinogenesis. 2000 Mar;21(3):525-30. doi: 10.1093/carcin/21.3.525. Carcinogenesis. 2000. PMID: 10688873 Review.

7

Synthetic triterpenoids, CDDO-Imidazolide and CDDO-Ethyl amide, induce chondrogenesis.

Suh N, Paul S, Lee HJ, Yoon T, Shah N, Son AI, Reddi AH, Medici D, Sporn MB. Suh N, et al. Among authors: sporn mb. Osteoarthritis Cartilage. 2012 May;20(5):446-450. doi: 10.1016/j.joca.2012.01.018. Epub 2012 Feb 2. Osteoarthritis Cartilage. 2012. Retraction in: Osteoarthritis Cartilage. 2020 Jun;28(6):865. doi: 10.1016/j.joca.2020.05.005 PMID: 22343171 Free article. Retracted.

8

Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.

Konopleva M, Tsao T, Ruvolo P, Stiouf I, Estrov Z, Leysath CE, Zhao S, Harris D, Chang S, Jackson CE, Munsell M, Suh N, Gribble G, Honda T, May WS, Sporn MB, Andreeff M. Konopleva M, et al. Among authors: sporn mb. Blood. 2002 Jan 1;99(1):326-35. doi: 10.1182/blood.v99.1.326. Blood. 2002. PMID: 11756188 Free article.

9

The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells.

Stadheim TA, Suh N, Ganju N, Sporn MB, Eastman A. Stadheim TA, et al. J Biol Chem. 2002 May 10;277(19):16448-55. doi: 10.1074/jbc.M108974200. Epub 2002 Mar 5. J Biol Chem. 2002. PMID: 11880365 Free article.

10

CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha.

Koschmieder S, D'Alò F, Radomska H, Schöneich C, Chang JS, Konopleva M, Kobayashi S, Levantini E, Suh N, Di Ruscio A, Voso MT, Watt JC, Santhanam R, Sargin B, Kantarjian H, Andreeff M, Sporn MB, Perrotti D, Berdel WE, Müller-Tidow C, Serve H, Tenen DG. Koschmieder S, et al. Among authors: sporn mb. Blood. 2007 Nov 15;110(10):3695-705. doi: 10.1182/blood-2006-11-058941. Epub 2007 Aug 1. Blood. 2007. PMID: 17671235 Free PMC article. Clinical Trial.

519 results

Page of 52